NCT04161118 TisaGenlecleucel in Elderly Patients With First-Relapsed or Primary Refractory Aggressive B-cell Non-Hodgkin Lymphoma Status TERMINATED Phase PHASE2
NCT04128943 Electronic Patient-reported Outcome Monitoring in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria Status COMPLETED Phase N/A
NCT04116502 MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera Status RECRUITING Phase PHASE3
NCT04055493 Adj. Marker-adjusted Personalized Therapy Comparing ET+Ribociclib vs Chemotherapy in Intermediate Risk, HR+/HER2- EBC Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04028245 A Study of Combination Spartalizumab and Canakinumab in Patients With Localized Clear Cell Renal Cell Carcinoma Status COMPLETED Phase EARLY_PHASE1
NCT04025502 Event-Related Potential (ERP) Biomarkers in Subjects With Schizophrenia and Healthy Volunteer Subjects Status COMPLETED Phase N/A
NCT03974360 Efficacy and Tolerability of Erenumab in the Prophylactic Treatment of Persistent Post-Traumatic Headache Status COMPLETED Phase PHASE2
NCT03959462 Supporting Decisions With Transcranial Direct Current Stimulation in Healthy Young and Elderly Individuals Status COMPLETED Phase NA
NCT03958136 Clinico-biological Data Collection Study of Metastatic Breast Cancer Status ACTIVE_NOT_RECRUITING Phase NA
NCT03944434 FACILE: FeAsibility of First-line RiboCIclib in OLdEr Patients with Advanced Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03927144 Study of Sustained Benefit of AMG334 in Adult Episodic Migraine Patients Status COMPLETED Phase PHASE4
NCT03912337 Effect of Erenumab-aooe on Disability and Work Productivity in Employed Subjects With Episodic Migraine Status TERMINATED Phase PHASE4
NCT03866317 A Study to Assess the Safety and Efficacy of Secukinumab in Alleviating Symptoms of Discoid Lupus Erythematosus Status WITHDRAWN Phase PHASE2